|
Welcome,
Guest
|
Profile for Neoadjuvant nivolumab in addition ipilimumab throughout resectable non-small mobile or portable cancer of the lung. (farmbit80)
|
Signature
|
|
Welcome,
Guest
|
|
Signature
|